Document Preview Unavailable
Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib
You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library